Showing results (2031-2040 of 2,192) with videos related to

Sort By:
Pageof 220
Frontiers in Psychology|August 19, 2022
Multi-informant validity evidence for the SSIS SEL Brief Scales across six European countriesChristopher J Anthony, Stephen N Elliott, Michayla Yost, et al.
The Journal of Experimental Medicine|February 16, 2024
A TNF-IL-1 circuit controls Yersinia within intestinal pyogranulomasRina Matsuda, Daniel Sorobetea, Jenna Zhang, et al.
Plos Medicine|November 23, 2013
A brief Patient-Reported Outcomes Quality of Life (PROQOL) instrument to improve patient careJennifer L Ridgeway, Timothy J Beebe, Christopher G Chute, et al.
Annals of Internal Medicine|September 18, 2023
Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2)Amir Qaseem, Jennifer Yost, George M Abraham, et al.
Cancer Immunology, Immunotherapy : CII|June 9, 2023
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancerColt A Egelston, Weihua Guo, Susan E Yost, et al.
AJNR. American Journal of Neuroradiology|January 24, 2015
Correlation of the Patient Reported Outcomes Measurement Information System with legacy outcomes measures in assessment of response to lumbar transforaminal epidural steroid injectionsL Shahgholi, K J Yost, R E Carter, et al.
Mbio|September 9, 2025
TNF signaling maintains local restriction of bacterial founder populations in intestinal and systemic sites during oral Yersinia infectionStefan T Peterson, Katherine G Dailey, Karthik Hullahalli, et al.
The Journal of Cell Biology|March 13, 2013
Rer1p maintains ciliary length and signaling by regulating γ-secretase activity and Foxj1a levelsNathalie Jurisch-Yaksi, Applonia J Rose, Huiqi Lu, et al.
Annals of Internal Medicine|January 23, 2023
Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of PhysiciansAmir Qaseem, Douglas K Owens, Itziar Etxeandia-Ikobaltzeta, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2021
Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Pageof 220